| NCT Number | NCT07403201 |
| Lead Sponsor | Inlacinpenelitian |
| Conditions | Polycystic Ovary Syndrome |
| Enrollment | 90 participants |
| Start Date | 2021-12-15 |
| Primary Completion | 2026-01-31 (estimated) |
| Study Completion | 2026-01-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-02-11 |